Innovative Vision Tech Clerio Vision is building a transformative laser-based vision correction platform (LIRIC) that alters the refractive index of existing materials, presenting a unique value proposition for premium ophthalmic solutions and potential partnerships with clinics seeking differentiated offerings.

ARVO and Wavefront Momentum Active engagement with major ophthalmology conferences (ARVO and Wavefront Congress) and announcements of breakthrough data suggest opportunities to co-present, co-develop, or sponsor clinical studies with eye care providers and research centers.

LCA Contact Lens The world’s first soft contact lens capable of correcting and reversing longitudinal chromatic aberration indicates a product pipeline extension into still-nascent contact lens therapies, opening upsell paths to optometrists and vision-corrective retailers.

Growing Financial Capacity With funding of fifty-one million dollars and revenue in the low to mid single-digit millions, Clerio Vision has resources for pilot programs, clinical collaborations, and scaled manufacturing partnerships to accelerate market entry.

Strategic Partnerships Small-to-mid sized team size combined with a high-visibility research agenda positions Clerio Vision as an attractive partner for contract research organizations, laser equipment suppliers, and specialty eye care networks seeking innovative treatment modalities.